Skip to main content

Peer Review reports

From: Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

Original Submission
16 Jan 2009 Submitted Original manuscript
2 Apr 2009 Reviewed Reviewer Report - David Kent
25 Apr 2009 Author responded Author comments - The ACT Trial Investigators
Resubmission - Version 2
25 Apr 2009 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
28 May 2009 Author responded Author comments - The ACT Trial Investigators
Resubmission - Version 4
28 May 2009 Submitted Manuscript version 4
Publishing
4 Jun 2009 Editorially accepted
4 Jun 2009 Article published 10.1186/1745-6215-10-38

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215